290 related articles for article (PubMed ID: 29091866)
1. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
[TBL] [Abstract][Full Text] [Related]
2. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
[TBL] [Abstract][Full Text] [Related]
3. UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Xu H; Yu H; Zhang X; Shen X; Zhang K; Sheng H; Dai S; Gao H
Int J Clin Exp Pathol; 2013; 6(4):711-7. PubMed ID: 23573318
[TBL] [Abstract][Full Text] [Related]
4. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
5. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of autophagy-related marker ULK1 and mitochondrion-associated autophagy inhibitor LRPPRC are associated with biochemical progression and overall survival after androgen deprivation therapy in patients with metastatic prostate cancer.
Zhang HY; Ma YD; Zhang Y; Cui J; Wang ZM
J Clin Pathol; 2017 May; 70(5):383-389. PubMed ID: 27679555
[TBL] [Abstract][Full Text] [Related]
7. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
8. ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.
Yun M; Bai HY; Zhang JX; Rong J; Weng HW; Zheng ZS; Xu Y; Tong ZT; Huang XX; Liao YJ; Mai SJ; Ye S; Xie D
PLoS One; 2015; 10(2):e0117375. PubMed ID: 25714809
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
[TBL] [Abstract][Full Text] [Related]
15. Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
Rajak S; Raza S; Tewari A; Yadav S; Ghosh S; Yen PM; Sinha RA
Biochem Biophys Res Commun; 2020 Nov; 532(4):570-575. PubMed ID: 32900486
[TBL] [Abstract][Full Text] [Related]
16. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
18. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of RYBP expression in primary hepatocellular carcinoma].
Jing X; Cai W; Huang B; Chen H; Chen D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):399-405. PubMed ID: 31113915
[TBL] [Abstract][Full Text] [Related]
20. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
